Stephanie Sue Gelman, MD | |
6360 S 3000 E, Ste 230, Cottonwood Heights, UT 84121-6923 | |
(801) 748-1173 | |
(801) 748-1163 |
Full Name | Stephanie Sue Gelman |
---|---|
Gender | Female |
Speciality | Infectious Disease |
Experience | 28 Years |
Location | 6360 S 3000 E, Cottonwood Heights, Utah |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114017712 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RI0200X | Internal Medicine - Infectious Disease | 347168-1205 (Utah) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Intermountain Homecare Home Health Salt Lake | South jordan, UT | Home health agency |
Intermountain Medical Center | Murray, UT | Hospital |
Riverton Hospital | Riverton, UT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
News Archive
"Long before the earthquake, Haiti was mired in a crisis that only a few experts noticed - a severe lack of clean drinking water," writes Joseph Treaster, editor of the University of Miami's Internet magazine on global water issues and the environment, in a Miami Herald opinion piece that examines the interconnectedness between water and health problems in Haiti, as well as other countries around the world.
Jazz Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has accepted for filing the New Drug Application (NDA) for JZP-6 (sodium oxybate) for the treatment of fibromyalgia.
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced it has begun the process of miniaturizing the optical biosensor platform developed in cooperation with Los Alamos National Laboratory.
Pediatric researchers analyzing genetic influences in attention-deficit/hyperactivity disorder (ADHD) have found alterations in specific genes involved in important brain signaling pathways. The study raises the possibility that drugs acting on those pathways might offer a new treatment option for patients with ADHD who have those gene variants—potentially, half a million U.S. children.
› Verified 5 days ago
Entity Name | Ihc Health Services Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1629260880 PECOS PAC ID: 1850209420 Enrollment ID: O20031105000079 |
News Archive
"Long before the earthquake, Haiti was mired in a crisis that only a few experts noticed - a severe lack of clean drinking water," writes Joseph Treaster, editor of the University of Miami's Internet magazine on global water issues and the environment, in a Miami Herald opinion piece that examines the interconnectedness between water and health problems in Haiti, as well as other countries around the world.
Jazz Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has accepted for filing the New Drug Application (NDA) for JZP-6 (sodium oxybate) for the treatment of fibromyalgia.
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced it has begun the process of miniaturizing the optical biosensor platform developed in cooperation with Los Alamos National Laboratory.
Pediatric researchers analyzing genetic influences in attention-deficit/hyperactivity disorder (ADHD) have found alterations in specific genes involved in important brain signaling pathways. The study raises the possibility that drugs acting on those pathways might offer a new treatment option for patients with ADHD who have those gene variants—potentially, half a million U.S. children.
› Verified 5 days ago
Entity Name | Ihc Health Services Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
"Long before the earthquake, Haiti was mired in a crisis that only a few experts noticed - a severe lack of clean drinking water," writes Joseph Treaster, editor of the University of Miami's Internet magazine on global water issues and the environment, in a Miami Herald opinion piece that examines the interconnectedness between water and health problems in Haiti, as well as other countries around the world.
Jazz Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has accepted for filing the New Drug Application (NDA) for JZP-6 (sodium oxybate) for the treatment of fibromyalgia.
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced it has begun the process of miniaturizing the optical biosensor platform developed in cooperation with Los Alamos National Laboratory.
Pediatric researchers analyzing genetic influences in attention-deficit/hyperactivity disorder (ADHD) have found alterations in specific genes involved in important brain signaling pathways. The study raises the possibility that drugs acting on those pathways might offer a new treatment option for patients with ADHD who have those gene variants—potentially, half a million U.S. children.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Stephanie Sue Gelman, MD 7929 Forest Oaks Ct, Salt Lake City, UT 84121-5737 Ph: (801) 274-0317 | Stephanie Sue Gelman, MD 6360 S 3000 E, Ste 230, Cottonwood Heights, UT 84121-6923 Ph: (801) 748-1173 |
News Archive
"Long before the earthquake, Haiti was mired in a crisis that only a few experts noticed - a severe lack of clean drinking water," writes Joseph Treaster, editor of the University of Miami's Internet magazine on global water issues and the environment, in a Miami Herald opinion piece that examines the interconnectedness between water and health problems in Haiti, as well as other countries around the world.
Jazz Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has accepted for filing the New Drug Application (NDA) for JZP-6 (sodium oxybate) for the treatment of fibromyalgia.
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced it has begun the process of miniaturizing the optical biosensor platform developed in cooperation with Los Alamos National Laboratory.
Pediatric researchers analyzing genetic influences in attention-deficit/hyperactivity disorder (ADHD) have found alterations in specific genes involved in important brain signaling pathways. The study raises the possibility that drugs acting on those pathways might offer a new treatment option for patients with ADHD who have those gene variants—potentially, half a million U.S. children.
› Verified 5 days ago
Dr. Jessica Stearns, D.O. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 6975 Union Park Ave, Suite 600 Office 679, Cottonwood Heights, UT 84047 Phone: 801-382-9006 | |
Dr. Kavita G Willesen, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 6965 S Union Park Ctr Ste 430, Cottonwood Heights, UT 84047 Phone: 385-308-8937 |